Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umeclidinium/Vilanterol vs Tiotropium in COPD
NCT01777334Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2013
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of umeclidinium, vilanterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jan 2013; status: completed.
02
Drugs
umeclidiniumvilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01777334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777334.